DMSO vs. DMSO-Free Cryopreservation

The most widely used cryoprotectant also carries known toxicity considerations. Here's how the two approaches actually compare.

Why DMSO Became the Standard

Dimethyl sulfoxide (DMSO) has been the dominant cryoprotectant in cell and tissue banking for decades. It's effective because it penetrates cell membranes and interferes with ice crystal formation both inside and outside the cell, meaningfully improving post-thaw survival compared to freezing without a cryoprotectant.

The Known Trade-Off

DMSO's effectiveness comes with a documented downside: it has dose-dependent toxicity to cells, and in clinical use it has been associated with infusion-related reactions in patients — including nausea, flushing, and, less commonly, more significant cardiovascular or neurological reactions — particularly with larger volumes or rapid infusion. This is well established in the hematopoietic stem cell transplant literature, where DMSO-preserved products have been in use the longest.

Because of this, some protocols call for washing or diluting DMSO-preserved products before administration to reduce patient exposure — an extra processing step with its own potential impact on cell viability.

DMSO-Free Alternatives

DMSO-free cryopreservation media use alternative, chemically defined formulations — designed to protect against freeze/thaw damage through mechanisms other than DMSO's membrane-penetrating action — with the goal of achieving comparable or improved post-thaw viability without DMSO's toxicity profile or the need for a wash step before administration.

This page is educational reference material for licensed healthcare providers and does not constitute medical, legal, or regulatory advice. HCT/P products are not FDA-approved.